| Record ID | marc_university_of_toronto/uoft.marc:4928606362:1660 |
| Source | University of Toronto |
| Download Link | /show-records/marc_university_of_toronto/uoft.marc:4928606362:1660?format=raw |
LEADER: 01660cam 2200373 a 4500
001 ocm59684685
005 20050824022013.0
008 050325s2005 onca bt 000 0 eng
020 $a1894978544 (print)
020 $a1894978552 (online)
029 0 $aNLM$b101244693
039 $fsom
042 $anlmcopyc
060 00 $a2005 D-889
060 10 $aQU 55$bG5873 2005
245 00 $aGlycoprotein IIb/IIIa antagonists :$ba systematic review of randomized clinical trials in patients undergoing percutaneous coronary intervention /$cChuong Ho ... [et al.].
260 $aOttawa :$bCanadian Coordinating Office for Health Technology Assessment,$c[2005]
300 $avi, 72 p. :$bill.
490 1 $aTechnology report ;$vissue 49
500 $a"January 2005."
504 $aIncludes bibliographical references (p. 27-30).
650 0 $aPlatelet glycoprotein GPIIb-IIIa complex$xInhibitors$xTherapeutic use.
650 0 $aCoronary heart disease$xChemotherapy.
650 12 $aPlatelet Glycoprotein GPIIb-IIIa Complex$xtherapeutic use.
650 22 $aCoronary Disease$xdrug therapy.
650 22 $aCoronary Disease$xsurgery.
650 22 $aRandomized Controlled Trials.
650 22 $aReview Literature.
650 22 $aTreatment Outcome.
700 1 $aHo, Chuong.
710 2 $aCanadian Coordinating Office for Health Technology Assessment.
830 0 $aTechnology report (Canadian Coordinating Office for Health Technology Assessment) ;$vissue 49.
949 $aRC685 .V6 G59 2005$wLC$c1$i31761062423298$d18/10/2005$e14/9/2005$lSTACKS$mGERSTEIN$n1$rY$sY$tBOOK$u25/8/2005
949 $aWG300 .G568 2005$wLC$c1$i92011753$lSTACKS$mSUNNYBROOK$rY$sY$tBOOK$u25/9/2007